August 2026
- Monoclonal Gammopathy of Undetermined Significance
- Case 24-2026: A 74-Year-Old Man with Dyspnea, Proximal Muscle Weakness, and Hypoxemia
- Placement of a Catheter for Acute Peritoneal Dialysis
- Mucolytics in Respiratory Failure — A MARCH Forward
- Jaccoud’s Arthropathy
- Severe Plasmodium falciparum Malaria
- Hydroxyurea for Ugandan Children with Sickle Cell Anemia
- Biologic Ventricular Assist Tissue in Heart Failure
- Oral Ivermectin and 5% Permethrin Cream for Severe Scabies
- Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea
- Myeloproliferative Neoplasms
- No to Azithromycin for Preschoolers with Acute Wheezing in the Emergency Department
- Antiretroviral Therapy
- Marijuana Rescheduling — A Game Changer for Research?
- The Broader Dangers of Abandoning SGM Health Research
- Farewell to All This
- Drug-Induced Subacute Cutaneous Lupus Erythematosus
- Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy
- Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment
- Crew Resource Management — Navigating AI’s Automation Paradox
- Andes Virus — A Clinical Review
- Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
- Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression
- Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.
- Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
- Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema
- Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock
- Vasopressors or Fluids in Early Septic Shock
- Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
- Carbocisteine or Hypertonic Saline for Acute Respiratory Failure
- Survodutide Once Weekly for the Treatment of Adults with Obesity
- Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
- Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease
- Obexelimab for the Treatment of IgG4-Related Disease
- First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
- Azithromycin for Preschoolers with Wheezing in the Emergency Department
- Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock